Relationship between the functional effect of tamsulosin and its concentration in lower urinary tract tissues in dogs

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 3, 2007, Pages 481-486

  Sato, Shuichi ^a   Ohtake, Akiyoshi ^a   Hatanaka, Toshiki ^a   Suzuki, Masanori ^a   Matsushima, Hiroshi ^a   Sasamata, Masao ^a   Miyata, Keiji ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Prostate; Retention; Tamsulosin; Tissue concentration; Urethral pressure

Indexed keywords

PHENYLEPHRINE; TAMSULOSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLADDER; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG RETENTION; DRUG TISSUE LEVEL; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; NONHUMAN; PROSTATE; URETHRA; URETHRA PRESSURE;

ADMINISTRATION, ORAL; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AREA UNDER CURVE; BLOOD PRESSURE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; HALF-LIFE; MALE; MESENTERIC ARTERIES; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PHENYLEPHRINE; PROSTATE; SULFONAMIDES; TREATMENT OUTCOME; URETHRA; URINARY BLADDER; URODYNAMICS;

EID: 33847690729     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.481     Document Type: Article

References (26)

1. Caine M., J. Urol., 136, 1-4 (1986).
2. Chapple C. R., Eur. Urol., 29, 129-144 (1996).
3. Lepor H., Prostate, 3 (Suppl.), 75-84 (1990).
4. Michel M. C., Kenny B., Schwinn D. A., Naunyn-Schmiedebergs Arch. Pharmacol., 352, 1-10 (1995).
5. Hieble J. P., Bylund D. B., Clarke D. E., Eikenburg D. C., Langer S. Z., Lefkowitz R. J., Minneman K. P., Ruffolo R. R., Jr., Pharmacol. Rev., 47, 267-270 (1995).
6. Price D. T., Schwinn D. A., Lomasney J. W., Allen L. F., Caron M. G., Lefkowitz R. J., J. Urol., 150, 546-551 (1993).
7. Nasu K., Moriyama N., Fukasawa R., Tsujimoto G., Tanaka T., Yano J., Kawabe K., Br. J. Pharmacol., 123, 1289-1293 (1998).
8. Forray C., Bard J. A., Wetzel J. M., Chiu G., Shapiro E., Tang R., Lepor H., Hartig P. R., Weinshank R. L., Branchek T. A., Gluchowski C., Mol. Pharmacol., 45, 703-708 (1994).
9. Lepor H., Urology, 51, 892-900 (1998).
10. Narayan P., Tewari A., J. Urol., 160, 1701-1706 (1998).
11. Takenaka T., Fujikura T., Honda K., Asano M., Niigata K., Yakugaku Zasshi, 115, 773-789 (1995).
12. Foglar R., Shibata K., Horie K., Hirasawa A., Tsujimoto G., Eur. J. Pharmacol., 288, 201-207 (1995).
13. Leonardi A., Hieble J. P., Guarneri L., Naselsky D. P., Poggesi E., Sironi G., Sulpizio A. C., Testa R., J. Pharmacol. Exp. Ther., 281, 1272-1283 (1997).
14. Taguchi K., Saitoh M., Sato S., Asano M., Michel M. C., J. Pharmacol. Exp. Ther., 280, 1-5 (1997).
15. Djavan B., Marberger M., Eur. Urol., 36, 1-13 (1999).
16. Chapple C. R., Eur. Urol., 34 (Suppl. 2), 10-17 (1998).
17. Sato S., Ohtake A., Matsushima H., Saito C., Usuda S., Miyata K., J. Pharmacol. Exp. Ther., 296, 697-703 (2001).
18. Brune M. E., Katwala S. P., Milicic I., Buckner S. A., Ireland L. M., Kerwin J. F., Jr., Hancock A. A., Pharmacology, 53, 356-368 (1996).
19. Soeishi Y., Kobori M., Kobayashi S., Higuchi S., J. Chromatogr., 533, 291-296 (1990).
20. Matsushima H., Takanuki K., Kamimura H., Watanabe T., Higuchi S., J. Chromatogr. B, 695, 317-327 (1997).
21. Noble A. J., Chess-Williams R., Couldwell C., Furukawa K., Uchyiuma T., Korstanje C., Chapple C. R., Br. J. Pharmacol., 120, 231-238 (1997).
22. Ohkura T., Yamada S., Deguchi Y., Kimura R., Matsushima H., Higuchi S., Inagaki O., Honda K., Takenaka T., Life Sci., 63, 2147-2155 (1998).
23. Yamada S., Tanaka C., Ohkura T., Mori R., Kimura R., Inagaki O., Honda K., Kawabe K., Urol. Res., 22, 273-278 (1994).
24. Honda K., Nakagawa C., J. Pharmacol. Exp. Ther., 239, 512-516 (1986).
25. Hancock A. A., Brune M. E., Witte D. G., Marsh K. C., Katwala S. , Milicic I., Ireland L. M., Crowell D., Meyer M. D., Kerwin J. F., Jr., J. Pharmacol. Exp. Ther., 285, 628-642 (1998).
26. Martin D. J., Lluel P., Pouyet T., Rauch-Desanti C., Angel I., Life Sci., 63, 169-176 (1998).